Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NantHealth, Inc. (NH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.4264+0.0088 (+2.11%)
At close: 04:00PM EDT
0.4400 +0.01 (+3.19%)
After hours: 06:29PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close0.4176
Open0.4155
Bid0.4022 x 2200
Ask0.4399 x 1800
Day's Range0.4140 - 0.4360
52 Week Range0.4030 - 2.5100
Volume47,237
Avg. Volume135,891
Market Cap49.271M
Beta (5Y Monthly)1.70
PE Ratio (TTM)N/A
EPS (TTM)-0.5100
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NantHealth, Inc.
    Analyst Report: Illumina IncIllumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses. The company's portfolio of products and services are designed to accelerate and simplify genetic analysis. The company also invests in startup companies that are pursuing promising genomic-related opportunities. It has roughly 9,100 full-time employees. ILMN shares are included in the S&P 500 index.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement